Gene Editing
FDA advisory panel votes unanimously that Pfizer and Moderna shots be authorized for young children
For an archived version of a live blog about Wednesday’s FDA advisory panel hearing, click here.
A panel of advisers convened by the Food and Drug Administration voted unanimously Wednesday to recommend that the Covid vaccines made by Pfizer-BioNTech and Moderna be made available to children as young as six months old.
